Abstract
* A new selective serotonin reuptake inhibitor, vilazodone hydrochloride (Viibryd), has been approved for the treatment of depression.
* Vilazodone's mechanism of action is similar to that of other drugs in the class, and it carries similar warnings and precautions.
* Vilazodone should be taken with food, which increases its bioavailability.